ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $195,589 | -41.2% | 61,700 | -7.8% | 0.05% | -41.0% |
Q2 2023 | $332,742 | +141.0% | 66,950 | +139.5% | 0.08% | +136.4% |
Q1 2023 | $138,073 | -21.5% | 27,950 | 0.0% | 0.03% | -23.3% |
Q4 2022 | $175,806 | +49.0% | 27,950 | +155.3% | 0.04% | +34.4% |
Q3 2022 | $118,000 | -67.7% | 10,950 | -65.8% | 0.03% | -67.0% |
Q2 2022 | $365,000 | +51.5% | 32,000 | +20.8% | 0.10% | +76.4% |
Q1 2022 | $241,000 | +148.5% | 26,500 | +307.7% | 0.06% | +175.0% |
Q4 2021 | $97,000 | -88.1% | 6,500 | -79.5% | 0.02% | -88.5% |
Q3 2021 | $815,000 | -6.1% | 31,725 | -4.7% | 0.17% | -7.0% |
Q2 2021 | $868,000 | +72.2% | 33,300 | +66.9% | 0.19% | +50.8% |
Q4 2020 | $504,000 | +55.6% | 19,950 | +132.0% | 0.12% | +26.5% |
Q3 2020 | $324,000 | +653.5% | 8,600 | +760.0% | 0.10% | +553.3% |
Q2 2020 | $43,000 | -2.3% | 1,000 | -55.6% | 0.02% | -34.8% |
Q1 2020 | $44,000 | +37.5% | 2,250 | +80.0% | 0.02% | +53.3% |
Q4 2019 | $32,000 | – | 1,250 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |